
Indoco Remedies Limited has informed the Exchange regarding a press release dated May 23, 2025, titled "Indoco Remedies receives final approval from the USFDA for Allopurinol Tablets USP 200 mg".
Filed with NSE ·

Indoco Remedies Limited has informed the Exchange regarding a press release dated May 23, 2025, titled "Indoco Remedies receives final approval from the USFDA for Allopurinol Tablets USP 200 mg".
6ix hasn’t read this filing yet.
Indoco Remedies Limited on 6ix
Follow Indoco Remedies into a list and get an email when it puts out news.
Follow Indoco Remedies